These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 3533264

  • 1. Comparative evaluation of captopril and methyldopa monotherapy for hypertension: double-blind study in Indians.
    Tahiliani R, Khokhani RC, Damle VB, Dadkar VN, Jaguste VS, Patel K, Raghu CN, Oke VG.
    Clin Ther; 1986; 8(5):482-9. PubMed ID: 3533264
    [Abstract] [Full Text] [Related]

  • 2. Clinical trial of captopril (Aceten) in Indian patients with essential hypertension.
    Shah BP, Patel K, Oke VG, Raghu CN.
    Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):415-20. PubMed ID: 3531033
    [Abstract] [Full Text] [Related]

  • 3. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.
    Cattin L, Da Col PG.
    Clin Ther; 1989 Aug; 11(3):363-72. PubMed ID: 2663164
    [Abstract] [Full Text] [Related]

  • 4. The effects of antihypertensive therapy on the quality of life.
    Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD, Klerman GL, Williams GH.
    N Engl J Med; 1986 Jun 26; 314(26):1657-64. PubMed ID: 3520318
    [Abstract] [Full Text] [Related]

  • 5. A double-blind evaluation of captopril in elderly hypertensives.
    Cox JP, Duggan J, O'Boyle CA, Mee F, Walsh JB, Coakley D, O'Brien E, O'Malley K.
    J Hypertens; 1989 Apr 26; 7(4):299-303. PubMed ID: 2656860
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Does the combination of ACE inhibitor and calcium antagonist control hypertension and improve quality of life? The LOMIR-MCT-IL study experience.
    Amir M, Cristal N, Bar-On D, Loidl A.
    Blood Press Suppl; 1994 Apr 26; 1():40-2. PubMed ID: 8205297
    [Abstract] [Full Text] [Related]

  • 8. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS, Farsky K, Bouchard S, Lalonde Y, Brookman S.
    Clin Ther; 1985 Apr 26; 7(2):199-204. PubMed ID: 3886142
    [Abstract] [Full Text] [Related]

  • 9. Comparative antihypertensive effects of guanabenz and methyldopa.
    Walker BR, Deitch MW, Schneider BE, Hare LE.
    Clin Ther; 1981 Apr 26; 4(4):275-84. PubMed ID: 7332915
    [Abstract] [Full Text] [Related]

  • 10. Enalapril versus captopril: a double-blind multicentre comparison in essential hypertension.
    Rumboldt Z, Marinković M, Drinovec J.
    Int J Clin Pharmacol Res; 1988 Apr 26; 8(3):181-8. PubMed ID: 2841251
    [Abstract] [Full Text] [Related]

  • 11. Muzolimine and nitrendipine in the treatment of arterial hypertension.
    de Divitiis O, Di Somma S, Petitto M, Galderisi M, Iacono C, Fazio S.
    Z Kardiol; 1985 Apr 26; 74 Suppl 2():60-5. PubMed ID: 3159163
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of a new antihypertensive agent ketanserin versus methyldopa in the treatment of essential hypertension in older patients: an international multicenter trial.
    Zin C, Copertari P, Landi E, San Martin C, Lopes M, Feruglio F, Alcocer L.
    J Cardiovasc Pharmacol; 1987 Apr 26; 10 Suppl 3():S113-8. PubMed ID: 2446057
    [Abstract] [Full Text] [Related]

  • 13. A double-blind comparison of transdermal clonidine and oral captopril in essential hypertension.
    McMahon FG, Jain AK, Vargas R, Fillingim J.
    Clin Ther; 1990 Apr 26; 12(2):88-100. PubMed ID: 2191779
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative efficacy of captopril and atenolol in moderately severe essential hypertension.
    Carey M, Blake S.
    Postgrad Med J; 1986 Apr 26; 62 Suppl 1():111-2. PubMed ID: 3317338
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Comparison of the efficacy and tolerability of sustained-release verapamil and captopril in mild to moderate essential arterial hypertension].
    Maarek-Charbit M, Stephan D, Welsch M, Galey-Arcangioli C, Imbs JL.
    Ann Cardiol Angeiol (Paris); 1991 Oct 26; 40(8):509-13. PubMed ID: 1759789
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Quality of life in normotensives compared to hypertensive men treated with isradipine or methyldopa as monotherapy or in combination with captopril: the LOMIR-MCT-IL study.
    Yodfat Y, Bar-On D, Amir M, Cristal N.
    J Hum Hypertens; 1996 Feb 26; 10(2):117-22. PubMed ID: 8867566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.